tiprankstipranks
Advertisement
Advertisement

NVNO Stock Latest News

enVVeno Medical reports Q2 EPS ($5.37) vs. ($11.52) last year
The FlyenVVeno Medical reports Q2 EPS ($5.37) vs. ($11.52) last year
2d ago
NVNO
enVVeno Medical sees cash runway into 3Q27
PremiumThe Fly
enVVeno Medical sees cash runway into 3Q27
2d ago
NVNO
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2H26
PremiumThe Fly
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2H26
2d ago
NVNO
enVVeno Medical highlights newly issued U.S. patent
PremiumThe Fly
enVVeno Medical highlights newly issued U.S. patent
18d ago
NVNO
enVVeno Medical Updates Investors With New Presentation
PremiumCompany Announcements
enVVeno Medical Updates Investors With New Presentation
18d ago
8K
NVNO
enVVeno Medical secures U.S. patent for enVVe system
PremiumThe FlyenVVeno Medical secures U.S. patent for enVVe system
26d ago
NVNO
enVVeno Medical upgraded to Buy from Neutral at Ladenburg
Premium
The Fly
enVVeno Medical upgraded to Buy from Neutral at Ladenburg
27d ago
NVNO
enVVeno Medical reports Q1 EPS ($5.89) vs. ($7.75) last year
Premium
The Fly
enVVeno Medical reports Q1 EPS ($5.89) vs. ($7.75) last year
3M ago
NVNO
enVVeno Medical sees cash runway into 3Q27
PremiumThe Fly
enVVeno Medical sees cash runway into 3Q27
3M ago
NVNO
enVVeno Medical says cash burn rate may increase to $4M-$5M per quarter
PremiumThe Fly
enVVeno Medical says cash burn rate may increase to $4M-$5M per quarter
3M ago
NVNO
enVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study
PremiumThe Fly
enVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study
3M ago
NVNO
enVVeno Medical Wins FDA IDE for TAVVE Trial
PremiumCompany Announcements
enVVeno Medical Wins FDA IDE for TAVVE Trial
3M ago
8K
NVNO
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year
PremiumThe FlyenVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year
4M ago
NVNO
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2026
Premium
The Fly
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2026
4M ago
NVNO
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO)
Premium
AI Analyst Ratings
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO)
4M ago
NVNO
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans
PremiumCompany Announcements
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans
6M ago
8K
NVNO
enVVeno Medical regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
enVVeno Medical regains compliance with Nasdaq minimum bid price rule
6M ago
NVNO
enVVeno Medical Executes One-for-35 Reverse Stock Split
PremiumCompany Announcements
enVVeno Medical Executes One-for-35 Reverse Stock Split
6M ago
8K
NVNO
Upcoming Stock Splits This Week (January 20 to January 23) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (January 20 to January 23) – Stay Invested
7M ago
PBM
BTOG
enVVeno Medical trading halted, news pending
PremiumThe FlyenVVeno Medical trading halted, news pending
7M ago
NVNO
enVVeno Medical board approves 1-for-35 reverse stock split
Premium
The Fly
enVVeno Medical board approves 1-for-35 reverse stock split
7M ago
NVNO
enVVeno Medical Holds Annual Stockholders Meeting
Premium
Company Announcements
enVVeno Medical Holds Annual Stockholders Meeting
8M ago
8K
NVNO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >